Send feedback

DSC2 p.Glu102Lys

c.304G>A · rs144799937 · VCV46189

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 20 submitters
AlphaMissense
likely benign
0.073 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.148%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
5
Cardiovascular phenotype

Computational evidence

Protein change
AlphaMissense0.073likely benign
REVEL0.277benign-leaning
SaProtLLR -5.95tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.2GERP 0.065, phastCons 0.48
Regional constrainto/e 0.98unconstrained · MANE · 34 kb · p 0.48 · regional, not allelic
Overall
CADD17.82PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.148% European (non-Finnish) · 1,749/1,179,532 alleles
Filtering AF 0.142% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.14%
Overall 0.123% 1,981/1,613,078 alleles · rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.22% 455
European (non-Finnish)grpmax 0.148% 674
Remaining individualsnot grpmax-eligible 0.123% 811
Middle Eastern 0.0661% 1,513
South Asian 0.0571% 1,750
Finnishnot grpmax-eligible 0.025% 3,999
Admixed American 0.02% 4,996
African / African-American 0.00802% 12,470

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DSC2
Protein
p.Glu102Lys
Coding
c.304G>A
MANE Select
NM_024422
dbSNP
rs144799937
Type
single nucleotide variant
Location
chr18:31092151 (GRCh38)
Gene constraint
LOEUF 0.743 · pLI <0.01 · ClinGen HI 1/3 (gnomAD)
Structure
AlphaFold pLDDT 77.26 · 3 PDB
Residue 102
a UniProt-annotated variant site (in arvd11; uncertain significance; abolishes localization at desmosomes and partially mis-localizes to the cytoplasm; uncertain significance)
Full DSC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dsc2-p-glu102lys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown